Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
PDA Journal of Pharmaceutical Science and Technology
|
June 22, 2016
On Statistical Approaches for Demonstrating Analytical Similarity in the Presence of Correlation
Harry Yang, Steven Novick, Richard K Burdick
Journal of Biopharmaceutical Statistics
|
February 17, 2016
A new PK equivalence test for a bridging study
Steven J Novick, Xiang Zhang, Harry Yang
PDA Journal of Pharmaceutical Science and Technology
|
August 13, 2016
Setting Alert and Action Limits in the Presence of Significant Amount of Censoring in Data
Steven J Novick, Wei Zhao, Harry Yang
Pharmaceutical Statistics
|
July 7, 2023
Modeling immunogenecity data to establish screening bioassays cut point
Jorge Quiroz, Satrajit Roychoudhury, Thomas Steinmetz, et al.
PDA Journal of Pharmaceutical Science and Technology
|
February 7, 2013
Environmental monitoring: setting alert and action limits based on a zero-inflated model
Harry Yang, Wei Zhao, Terrence O'day, et al.
Transplantation
|
July 23, 2009
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease
Douglas Adkins, Voravit Ratanatharathorn, Harry Yang, et al.
Journal of Immunological Methods
|
January 9, 2017
Immunogenicity assay cut point determination using nonparametric tolerance limit
Jianchun Zhang, Wenjia Li, Lorin K Roskos, et al.
Pharmaceutical Statistics
|
November 26, 2019
Comparisons of outlier tests for potency bioassays
Perceval Sondag, Lingmin Zeng, Binbing Yu, et al.
Journal of Immunological Methods
|
January 12, 2013
Statistical methods and tool for cut point analysis in immunogenicity assays
Lanju Zhang, Jianchun Jason Zhang, Robert J Kubiak, et al.
Journal of Biopharmaceutical Statistics
|
January 16, 2010
Tolerance limits for a ratio of normal random variables
Lanju Zhang, Thomas Mathew, Harry Yang, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
PDA Journal of Pharmaceutical Science and Technology
|
June 22, 2016
On Statistical Approaches for Demonstrating Analytical Similarity in the Presence of Correlation
Harry Yang, Steven Novick, Richard K Burdick
Journal of Biopharmaceutical Statistics
|
February 17, 2016
A new PK equivalence test for a bridging study
Steven J Novick, Xiang Zhang, Harry Yang
PDA Journal of Pharmaceutical Science and Technology
|
August 13, 2016
Setting Alert and Action Limits in the Presence of Significant Amount of Censoring in Data
Steven J Novick, Wei Zhao, Harry Yang
Pharmaceutical Statistics
|
July 7, 2023
Modeling immunogenecity data to establish screening bioassays cut point
Jorge Quiroz, Satrajit Roychoudhury, Thomas Steinmetz, et al.
PDA Journal of Pharmaceutical Science and Technology
|
February 7, 2013
Environmental monitoring: setting alert and action limits based on a zero-inflated model
Harry Yang, Wei Zhao, Terrence O'day, et al.
Transplantation
|
July 23, 2009
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease
Douglas Adkins, Voravit Ratanatharathorn, Harry Yang, et al.
Journal of Immunological Methods
|
January 9, 2017
Immunogenicity assay cut point determination using nonparametric tolerance limit
Jianchun Zhang, Wenjia Li, Lorin K Roskos, et al.
Pharmaceutical Statistics
|
November 26, 2019
Comparisons of outlier tests for potency bioassays
Perceval Sondag, Lingmin Zeng, Binbing Yu, et al.
Journal of Immunological Methods
|
January 12, 2013
Statistical methods and tool for cut point analysis in immunogenicity assays
Lanju Zhang, Jianchun Jason Zhang, Robert J Kubiak, et al.
Journal of Biopharmaceutical Statistics
|
January 16, 2010
Tolerance limits for a ratio of normal random variables
Lanju Zhang, Thomas Mathew, Harry Yang, et al.
Page
of 6